Page last updated: 2024-11-12
pterulone
Description
pterulone: isolated from Pterula coral fungus; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 11424846 |
CHEMBL ID | 450490 |
SCHEMBL ID | 6107143 |
MeSH ID | M0278032 |
Synonyms (11)
Synonym |
CHEMBL450490 |
369376-61-4 |
SCHEMBL6107143 |
pterulone |
1-[(3z)-3-(chloromethylidene)-1-benzoxepin-7-yl]ethanone |
Q7256974 |
ethanone, 1-((3z)-3-(chloromethylene)-2,3-dihydro-1-benzoxepin-7-yl)- |
a69767ww45 , |
1-((3z)-3-(chloromethylene)-2,3-dihydro-1-benzoxepin-7-yl)ethanone |
(z)-1-(3-(chloromethylene)-2,3-dihydro-1-benzoxepin-7-yl)ethanone |
unii-a69767ww45 |
Bioassays (4)
Assay ID | Title | Year | Journal | Article |
AID334229 | Antimicrobial activity against Saccharomyces cerevisiae CBS 1394 assessed as relative growth at 50 ug/mL after 24 to 48 hrs relative to control | 2002 | Journal of natural products, Apr, Volume: 65, Issue:4
| Total synthesis and bioactivity of some naturally occurring pterulones. |
AID334228 | Antimicrobial activity against Rhodotorula glutinis ATCC 201718 assessed as relative growth at 50 ug/mL after 24 to 48 hrs relative to control | 2002 | Journal of natural products, Apr, Volume: 65, Issue:4
| Total synthesis and bioactivity of some naturally occurring pterulones. |
AID334231 | Antimicrobial activity against Saccharomyces cerevisiae CBS 1394 assessed as relative growth at 100 ug/mL after 24 to 48 hrs relative to control | 2002 | Journal of natural products, Apr, Volume: 65, Issue:4
| Total synthesis and bioactivity of some naturally occurring pterulones. |
AID334230 | Antimicrobial activity against Rhodotorula glutinis ATCC 201718 assessed as relative growth at 100 ug/mL after 24 to 48 hrs relative to control | 2002 | Journal of natural products, Apr, Volume: 65, Issue:4
| Total synthesis and bioactivity of some naturally occurring pterulones. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (4)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |